Controlling stimulation strength and focality in electroconvulsive therapy via current amplitude and electrode size and spacing: comparison with magnetic seizure therapy.


Journal Article

OBJECTIVES: Understanding the relationship between the stimulus parameters of electroconvulsive therapy (ECT) and the electric field characteristics could guide studies on improving risk/benefit ratio. We aimed to determine the effect of current amplitude and electrode size and spacing on the ECT electric field characteristics, compare ECT focality with magnetic seizure therapy (MST), and evaluate stimulus individualization by current amplitude adjustment. METHODS: Electroconvulsive therapy and double-cone-coil MST electric field was simulated in a 5-shell spherical human head model. A range of ECT electrode diameters (2-5 cm), spacing (1-25 cm), and current amplitudes (0-900 mA) was explored. The head model parameters were varied to examine the stimulus current adjustment required to compensate for interindividual anatomical differences. RESULTS: By reducing the electrode size, spacing, and current, the ECT electric field can be more focal and superficial without increasing scalp current density. By appropriately adjusting the electrode configuration and current, the ECT electric field characteristics can be made to approximate those of MST within 15%. Most electric field characteristics in ECT are more sensitive to head anatomy variation than in MST, especially for close electrode spacing. Nevertheless, ECT current amplitude adjustment of less than 70% can compensate for interindividual anatomical variability. CONCLUSIONS: The strength and focality of ECT can be varied over a wide range by adjusting the electrode size, spacing, and current. If desirable, ECT can be made as focal as MST while using simpler stimulation equipment. Current amplitude individualization can compensate for interindividual anatomical variability.

Full Text

Duke Authors

Cited Authors

  • Deng, Z-D; Lisanby, SH; Peterchev, AV

Published Date

  • December 2013

Published In

Volume / Issue

  • 29 / 4

Start / End Page

  • 325 - 335

PubMed ID

  • 24263276

Pubmed Central ID

  • 24263276

Electronic International Standard Serial Number (EISSN)

  • 1533-4112

Digital Object Identifier (DOI)

  • 10.1097/YCT.10.1097/YCT.0b013e3182a4b4a7


  • eng

Conference Location

  • United States